Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 5 USD 2.67% Market Closed
Market Cap: 607.8m USD

P/OCF
Price to OCF

-3.4
Current
-3.2
Median
19.3
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-3.4
=
Market Cap
607.8m USD
/
Operating Cash Flow
-158m EUR
Market Cap P/OCF
DE
Immatics NV
NASDAQ:IMTX
607.8m USD -3.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -220 067.6
US
Abbvie Inc
NYSE:ABBV
341.3B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
153B USD 13.3
US
Gilead Sciences Inc
NASDAQ:GILD
129B USD 11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.2B USD -261
US
Epizyme Inc
F:EPE
94.1B EUR -511.2
AU
CSL Ltd
ASX:CSL
121.6B AUD 26.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
64.2B USD 14.5
US
Seagen Inc
F:SGT
39.3B EUR -82.5
NL
argenx SE
XBRU:ARGX
34.6B EUR -473
 
DE
Immatics NV
NASDAQ:IMTX
Average P/OCF: 16.9
Negative Multiple: -3.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -220 067.6
US
Abbvie Inc
NYSE:ABBV
18.2
US
Amgen Inc
NASDAQ:AMGN
13.3
US
Gilead Sciences Inc
NASDAQ:GILD
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -261
US
E
Epizyme Inc
F:EPE
Negative Multiple: -511.2
AU
CSL Ltd
ASX:CSL
26.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -82.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -473

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A